Profile
ABPWW NVO VRTX REGN SGEN ARGX
Company Name Abpro Holdings Inc Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.08M $292.61B $105.75B $77.45B $43.15B $38.15B
Employees 0.02K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Ian Chan Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABPWW NVO VRTX REGN SGEN ARGX
Quant Rating Score 3 3 4 3 1
Quant Rating Neutral Neutral Buy Neutral Strong Sell
Trading
ABPWW NVO VRTX REGN SGEN ARGX
Last Close $0.12 $87.65 $410.65 $716.68 $228.74 $632.04
High 52 $0.12 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $0.03 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High 0 % -40.34 % -20.53 % -40.36 % 0 % -0.99 %
Price vs. 52 Week Low 300 % 3.12 % 4.54 % 2.11 % 0 % 77.53 %
Total Return
ABPWW NVO VRTX REGN SGEN ARGX
1 Month Return 172.73 % -17.41 % -11.6 % -5.06 % 0 % 2.84 %
3 Month Return 0 % -27.42 % -11.28 % -31.27 % 0 % 17.89 %
6 Month Return 0 % -39.34 % -13.09 % -31.8 % 0 % 42.05 %
9 Month Return 0 % -31.55 % -1.6 % -25.83 % 0 % 58.57 %
YTD Return 0 % -15.27 % 0.92 % -18.4 % 0 % 66.14 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABPWW NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.54 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Profitability
ABPWW NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM 42.16 -90.87 22.93 -141.85 -180.64
Price To Operating Cash Flows Ratio TTM 24.15 -125.74 18.24 -203.89 -260.94
Price Cash Flow Ratio TTM 24.15 -125.74 18.24 -203.89 -260.94
Income Statement (TTM)
ABPWW NVO VRTX REGN SGEN ARGX
Revenue $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABPWW NVO VRTX REGN SGEN ARGX
Long Term Debt $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABPWW NVO VRTX REGN SGEN ARGX
Net Income $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $-31.77B $0B $0B $0B $0B
Operating Cash Flow $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.2435
ABCL AbCellera Biologics Inc. 2.95
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.66
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.81
ABSI Absci Corporation 2.785
ABUS Arbutus Biopharma Corporation 3.205
ABVC ABVC BioPharma, Inc. 0.6022
ABVX Abivax SA American Depositary Shares 7.2
ACAD ACADIA Pharmaceuticals Inc. 16.97
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9188
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.13
ACHV Achieve Life Sciences, Inc. 3.66
ACIU AC Immune SA 2.805
ACLX Arcellx, Inc. 78.72
ACRV Acrivon Therapeutics, Inc. Common Stock 5.92
ACST Acasti Pharma Inc. 3.37
Unlock